Enbrel
Enbrel is a pharmaceutical drug with 24 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
18 of 21 finished
14.3%
3 ended early
0
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
Clinical Trials (24)
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
Enbrel® in Psoriatic Arthritis
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24